Article
In the best of all worlds, ophthalmologists, whether in solo or group practice, would be able to solve practice problems before they became big enough to have an effect on overall performance. However, experience tells us otherwise.
First patient dosed at the Tokyo Medical Center by Belite Bio in Phase 2/3 DRAGON II clinical trial